Tenofovir Amibufenamide, a rising star in chronic hepatitis B...

agregó una foto Fitness

2026-01-13 08:34:05 - Translate

Tenofovir Amibufenamide, a rising star in chronic hepatitis B treatment: How to achieve significant therapeutic effects with low dosage?

2026-01-13 Written by DengyueMed Tenofovir Amibufenamide (Hengmu®) is a next-generation tenofovir prodrug independently developed in China for the treatment of chronic hepatitis B (CHB). Designed with optimized molecular structure and enhanced liver targeting, Tenofovir Amibufenamide delivers potent antiviral efficacy at a significantly lower dose, while offering a favorable long-term...

0 Commentarios 0 Acciones 4K Views 0 Vista previa